Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
Condition: Post-COVID-19 Syndrome Intervention: Drug: Methylprednisolone Sponsor: Charite University, Berlin, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials